Glen Baker - Publications

Neuroscience and Mental Health Institute University of Alberta, Edmonton, Alberta, Canada 

273 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Orzylowski M, Fujiwara E, Mousseau DD, Baker GB. An Overview of the Involvement of D-Serine in Cognitive Impairment in Normal Aging and Dementia. Frontiers in Psychiatry. 12: 754032. PMID 34707525 DOI: 10.3389/fpsyt.2021.754032  1
2021 Foster JA, Baker GB, Dursun SM. The Relationship Between the Gut Microbiome-Immune System-Brain Axis and Major Depressive Disorder. Frontiers in Neurology. 12: 721126. PMID 34650506 DOI: 10.3389/fneur.2021.721126  1
2021 Gammon D, Cheng C, Volkovinskaia A, Baker GB, Dursun SM. Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders? Biomolecules. 11. PMID 34356654 DOI: 10.3390/biom11071030  1
2021 Guo H, Baker G, Hartle K, Fujiwara E, Wang J, Zhang Y, Xing J, Lyu H, Li XM, Chen J. Exploratory study on neurochemical effects of low-intensity pulsed ultrasound in brains of mice. Medical & Biological Engineering & Computing. PMID 33881705 DOI: 10.1007/s11517-021-02351-9  1
2021 Matveychuk D, MacKenzie EM, Kumpula D, Song MS, Holt A, Kar S, Todd KG, Wood PL, Baker GB. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine. Cellular and Molecular Neurobiology. PMID 33839994 DOI: 10.1007/s10571-021-01078-3  1
2021 Dos Santos RG, Hallak JE, Baker G, Dursun S. Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action. Journal of Psychopharmacology (Oxford, England). 269881120986422. PMID 33740877 DOI: 10.1177/0269881120986422  1
2021 Le Melledo JM, Baker G, Gyenes G, Tsuyuki R, Jurasz P. L-Arginine and NOS activity, a complex relationship. Psychopharmacology. PMID 33595692 DOI: 10.1007/s00213-021-05799-7  1
2020 Igwe O, Sone M, Matveychuk D, Baker GB, Dursun SM. A review of effects of calorie restriction and fasting with potential relevance to depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110206. PMID 33316333 DOI: 10.1016/j.pnpbp.2020.110206  1
2020 Sharples SA, Burma NE, Borowska-Fielding J, Kwok CHT, Eaton SEA, Baker GB, Jean-Xavier C, Zhang Y, Trang T, Whelan PJ. A dynamic role for dopamine receptors in the control of mammalian spinal networks. Scientific Reports. 10: 16429. PMID 33009442 DOI: 10.1038/s41598-020-73230-w  1
2020 Mayr KA, Kwok CHT, Eaton SEA, Baker GB, Whelan PJ. The effects of a ketogenic diet on sensorimotor function in a thoracolumbar mouse spinal cord injury model. Eneuro. PMID 32680835 DOI: 10.1523/ENEURO.0178-20.2020  1
2020 Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB, Dursun SM. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Therapeutic Advances in Psychopharmacology. 10: 2045125320916657. PMID 32440333 DOI: 10.1177/2045125320916657  1
2019 Marinas JE, Matveychuk D, Dursun SM, Baker GB. Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry. Acta Neuropsychiatrica. 1-27. PMID 31791436 DOI: 10.1017/neu.2019.50  1
2019 Ahn KC, Learman CR, Baker GB, Weaver CL, Chung PS, Kim HG, Song MS. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease? Journal of Korean Medical Science. 34: e297. PMID 31779058 DOI: 10.3346/jkms.2019.34.e297  1
2019 Swainson J, Thomas RK, Archer S, Chrenek C, Baker G, Dursun S, MacKay MA, Klassen LJ, Chokka P, Demas ML. Esketamine for treatment resistant depression. Expert Review of Neurotherapeutics. PMID 31282772 DOI: 10.1080/14737175.2019.1640604  1
2019 Yu J, Wang DS, Bonin RP, Penna A, Alavian-Ghavanini A, Zurek AA, Rauw G, Baker GB, Orser BA. Gabapentin increases expression of δ subunit-containing GABA receptors. Ebiomedicine. PMID 30878595 DOI: 10.1016/J.Ebiom.2019.03.008  1
2019 Baker G, Matveychuk D, MacKenzie EM, Holt A, Wang Y, Kar S. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine. Chemico-Biological Interactions. PMID 30857888 DOI: 10.1016/J.Cbi.2019.03.003  1
2019 Quartey MO, Nyarko JNK, Pennington PR, Heistad RM, Chaharyn BM, Wei Z, Bainbridge D, Baker GB, Mousseau DD. Age- and sex-dependent profiles of APP fragments and key secretases align with changes in despair-like behavior and cognition in young APPSwe/Ind mice. Biochemical and Biophysical Research Communications. PMID 30803762 DOI: 10.1016/j.bbrc.2019.02.083  1
2019 MacKay MB, Kravtsenyuk M, Thomas R, Mitchell ND, Dursun SM, Baker GB. D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression? Frontiers in Psychiatry. 10: 25. PMID 30787885 DOI: 10.3389/fpsyt.2019.00025  1
2019 Dhami KS, Churchward MA, Baker GB, Todd KG. Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis. Journal of Neurochemistry. PMID 30613984 DOI: 10.1111/Jnc.14661  1
2018 MacKay MB, Paylor JW, Wong JTF, Winship IR, Baker GB, Dursun SM. Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics. Frontiers in Psychiatry. 9: 537. PMID 30425662 DOI: 10.3389/fpsyt.2018.00537  1
2018 Thomas RK, Baker G, Lind J, Dursun S. Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness. Journal of Psychopharmacology (Oxford, England). 269881118793104. PMID 30182797 DOI: 10.1177/0269881118793104  1
2018 Mifflin K, Baker GB, Kerr BJ. Effect of Voluntary Wheel Running on Neuroactive Steroid Levels in Murine Experimental Autoimmune Encephalomyelitis. Neuroscience Letters. PMID 30171909 DOI: 10.1016/j.neulet.2018.08.040  1
2018 Nyarko JNK, Quartey MO, Heistad RM, Pennington PR, Poon LJ, Knudsen KJ, Allonby O, El Zawily AM, Freywald A, Rauw G, Baker GB, Mousseau DD. Glycosylation States of Pre- and Post-synaptic Markers of 5-HT Neurons Differ With Sex and 5-HTTLPR Genotype in Cortical Autopsy Samples. Frontiers in Neuroscience. 12: 545. PMID 30147642 DOI: 10.3389/fnins.2018.00545  1
2018 Ahn KC, Baker GB, Jang WC, Cha HC, Moon MJ, Song MS. Roles of 5-HT on phase transition of neurite outgrowth in the identified serotoninergic neuron C1, Helisoma trivolvis. Invertebrate Neuroscience : In. 18: 10. PMID 30128715 DOI: 10.1007/s10158-018-0214-6  1
2018 Quartey MO, Nyarko JNK, Pennington PR, Heistad RM, Klassen PC, Baker GB, Mousseau DD. Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex. Frontiers in Neuroscience. 12: 419. PMID 29997470 DOI: 10.3389/fnins.2018.00419  1
2018 Potter LE, Doolen S, Mifflin K, Tenorio G, Baker G, Taylor BK, Kerr BJ. Antinociceptive effects of the antidepressant phenelzine are mediated by context-dependent inhibition of neuronal responses in the dorsal horn. Neuroscience. PMID 29752984 DOI: 10.1016/J.Neuroscience.2018.04.047  1
2018 Winship IR, Dursun SM, Baker GB, Balista PA, Kandratavicius L, Maia-de-Oliveira JP, Hallak J, Howland JG. An Overview of Animal Models Related to Schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743718773728. PMID 29742910 DOI: 10.1177/0706743718773728  1
2018 Nyarko JNK, Quartey MO, Baker GB, Mousseau DD. Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease? Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743718772514. PMID 29685068 DOI: 10.1177/0706743718772514  1
2018 Hamill J, Hallak J, Dursun SM, Baker G. Ayahuasca: Psychological And Physiologic Effects, Pharmacology And Potential Uses In Addiction And Mental Illness. Current Neuropharmacology. PMID 29366418 DOI: 10.2174/1570159X16666180125095902  1
2018 Nyarko JNK, Quartey MO, Pennington PR, Heistad RM, Dea D, Poirier J, Baker GB, Mousseau DD. Profiles of β-amyloid peptides and key secretases in brain autopsy samples differ with sex and APOE ε4 status: impact for risk and progression of Alzheimer disease. Neuroscience. PMID 29331531 DOI: 10.1016/J.Neuroscience.2018.01.005  1
2017 Asahchop EL, Meziane O, Mamik MK, Chan WF, Branton WG, Resch L, Gill MJ, Haddad E, Guimond JV, Wainberg MA, Baker GB, Cohen EA, Power C. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain. Retrovirology. 14: 47. PMID 29037245 DOI: 10.1186/S12977-017-0370-5  1
2017 Alpaugh M, Galleguillos D, Forero J, Morales LC, Lackey SW, Kar P, Di Pardo A, Holt A, Kerr BJ, Todd KG, Baker GB, Fouad K, Sipione S. Disease-modifying effects of ganglioside GM1 in Huntington's disease models. Embo Molecular Medicine. PMID 28993428 DOI: 10.15252/Emmm.201707763  1
2017 Baker GB, Saavedra JM. In Memoriam: Adil J. Nazarali. Cellular and Molecular Neurobiology. PMID 28916984 DOI: 10.1007/s10571-017-0551-8  0.01
2017 Cherkasova MV, Faridi N, Casey KF, Larcher K, O'Driscoll GA, Hechtman L, Joober R, Baker GB, Palmer J, Evans AC, Dagher A, Benkelfat C, Leyton M. Differential Associations between Cortical Thickness and Striatal Dopamine in Treatment-Naïve Adults with ADHD vs. Healthy Controls. Frontiers in Human Neuroscience. 11: 421. PMID 28878639 DOI: 10.3389/Fnhum.2017.00421  1
2017 Boghozian R, McKenzie BA, Saito LB, Mehta N, Branton WG, Lu J, Baker GB, Noorbakhsh F, Power C. Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation. Glia. PMID 28707358 DOI: 10.1002/Glia.23179  1
2017 Raitsin S, Tong J, Kish S, Xu X, Magomedova L, Cummins C, Andreazza AC, Scola G, Baker G, Meyer JH. Subchronic Glucocorticoids, Glutathione Depletion and a Postpartum Model Elevate Monoamine Oxidase A Activity in the Prefrontal Cortex of Rats. Brain Research. PMID 28435083 DOI: 10.1016/J.Brainres.2017.03.032  0.01
2017 Leduc RY, Rauw G, Baker GB, McDermid HE. What Goes Around Can Come Around: An Unexpected Deleterious Effect of Using Mouse Running Wheels for Environmental Enrichment. Journal of the American Association For Laboratory Animal Science : Jaalas. 56: 194-201. PMID 28315651  1
2017 Mifflin KA, Frieser E, Benson C, Baker G, Kerr BJ. Voluntary wheel running differentially affects disease outcomes in male and female mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 305: 135-144. PMID 28284334 DOI: 10.1016/j.jneuroim.2017.02.005  1
2017 Riske L, Thomas RK, Baker GB, Dursun SM. Lactate in the brain: an update on its relevance to brain energy, neurons, glia and panic disorder. Therapeutic Advances in Psychopharmacology. 7: 85-89. PMID 28255438 DOI: 10.1177/2045125316675579  1
2017 Melledo JML, Ghuman A, McEwen A, Burgess D, Hanstock C, Seres P, Khalili P, Newman S, Baker G, Mitchell N, Khudabux-Der J, Allen P. Glutamate levels in the medial prefrontal cortex during pregnancy European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31295-6  1
2016 Maia-de-Oliveira JP, Baker GB, Dursun SM, Hallak JE. Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained? Psychological Medicine. 1-2. PMID 27931266 DOI: 10.1017/S003329171600307X  1
2016 Alles SR, Bandet MV, Eppler K, Noh MC, Winship IR, Baker G, Ballanyi K, Smith PA. Acute anti-allodynic action of gabapentin in dorsal horn and primary somatosensory cortex: Correlation of behavioural and physiological data. Neuropharmacology. PMID 27856391 DOI: 10.1016/J.Neuropharm.2016.11.011  1
2016 Hurtubise JL, Marks WN, Davies DA, Catton JK, Baker GB, Howland JG. MK-801-induced impairments on the trial-unique, delayed nonmatching-to-location task in rats: effects of acute sodium nitroprusside. Psychopharmacology. PMID 27725997 DOI: 10.1007/S00213-016-4451-2  1
2016 Zheng HF, Wang WQ, Li XM, Rauw G, Baker GB. Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature. Amino Acids. PMID 27686223 DOI: 10.1007/s00726-016-2332-y  1
2016 Potter LE, Paylor JW, Suh JS, Tenorio G, Caliaperumal J, Colbourne F, Baker G, Winship I, Kerr BJ. Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis. Journal of Neuroinflammation. 13: 142. PMID 27282914 DOI: 10.1186/S12974-016-0609-4  1
2015 Mifflin K, Benson C, Thorburn K, Baker GB, Kerr BJ. Manipulation of neurotransmitter levels has differential effects on formalin evoked nociceptive behaviour in male and female mice. The Journal of Pain : Official Journal of the American Pain Society. PMID 26748043 DOI: 10.1016/j.jpain.2015.12.013  1
2015 Vivithanaporn P, Asahchop EL, Acharjee S, Baker GB, Power C. HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance. Aids (London, England). PMID 26558720 DOI: 10.1097/Qad.0000000000000955  1
2015 Benson C, Mifflin K, Kerr B, Jesudasan SJ, Dursun S, Baker G. Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression. Modern Trends in Pharmacopsychiatry. 30: 67-79. PMID 26437459 DOI: 10.1159/000435933  1
2015 Mifflin K, Benson C, Kerr B, Aricioglu F, Cetin M, Dursun S, Baker G. Involvement of Neuroactive Steroids in Pain, Depression and Anxiety. Modern Trends in Pharmacopsychiatry. 30: 94-102. PMID 26436548 DOI: 10.1159/000435935  1
2015 Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH. Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26316187 DOI: 10.1093/ijnp/pyv078  1
2015 Ohland CL, Pankiv E, Baker G, Madsen KL. Western diet-induced anxiolytic effects in mice are associated with alterations in tryptophan metabolism. Nutritional Neuroscience. PMID 26086200 DOI: 10.1179/1476830515Y.0000000034  0.01
2015 Boakye PA, Olechowski C, Rashiq S, Verrier MJ, Kerr B, Witmans M, Baker G, Joyce A, Dick BD. A Critical Review of Neurobiological Factors Involved in the Interactions between Chronic Pain, Depression, and Sleep Disruption. The Clinical Journal of Pain. PMID 26035521 DOI: 10.1097/Ajp.0000000000000260  1
2015 Benson C, Paylor JW, Tenorio G, Winship I, Baker G, Kerr BJ. Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE). Experimental Neurology. 271: 279-290. PMID 26033473 DOI: 10.1016/J.Expneurol.2015.05.017  1
2015 Kandratavicius L, Balista PA, Wolf DC, Abrao J, Evora PR, Rodrigues AJ, Chaves C, Maia-de-Oliveira JP, Leite JP, Dursun SM, Baker GB, Guimaraes FS, Hallak JE. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia. Bmc Neuroscience. 16: 9. PMID 25887360 DOI: 10.1186/S12868-015-0149-3  1
2015 Haile Y, Nakhaei-Nejad M, Boakye PA, Baker G, Smith PA, Murray AG, Giuliani F, Jahroudi N. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes. Plos One. 10: e0119617. PMID 25789622 DOI: 10.1371/Journal.Pone.0119617  1
2015 Maia-de-Oliveira JP, Lobão-Soares B, Ramalho T, Gavioli EC, Soares VP, Teixeira L, Baker GB, Dursun SM, Hallak JE. Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week. Schizophrenia Research. 162: 211-5. PMID 25586741 DOI: 10.1016/j.schres.2014.12.035  1
2015 Maia-de-Oliveira JP, Abrao J, Evora PR, Zuardi AW, Crippa JA, Belmonte-de-Abreu P, Baker GB, Dursun SM, Hallak JE. The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study. Journal of Clinical Psychopharmacology. 35: 83-5. PMID 25502490 DOI: 10.1097/JCP.0000000000000258  1
2015 Chaves C, Marque CR, Maia-de-Oliveira JP, Wichert-Ana L, Ferrari TB, Santos AC, Araújo D, Machado-de-Sousa JP, Bressan RA, Elkis H, Crippa JA, Guimarães FS, Zuardi AW, Baker GB, Dursun SM, et al. Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia. Schizophrenia Research. 161: 439-45. PMID 25497439 DOI: 10.1016/J.Schres.2014.11.031  1
2015 Kerr B, Benson C, Mifflin K, Jesudasan SJB, Dursun S, Baker G. Treatment of pain with antidepressants Klinik Psikofarmakoloji Bulteni. 25: 209-320. DOI: 10.5455/Bcp.20150825014707  1
2014 Maia-de-Oliveira JP, Lobão-Soares B, Baker GB, Dursun SM, Hallak JE. Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems. Schizophrenia Research. 159: 558-9. PMID 25223842 DOI: 10.1016/j.schres.2014.08.020  1
2014 Maia-de-Oliveira JP, Belmonte-de-Abreu P, Bressan RA, Cachoeira C, Baker GB, Dursun SM, Hallak JE. Sodium nitroprusside treatment of clozapine-refractory schizophrenia. Journal of Clinical Psychopharmacology. 34: 761-3. PMID 25203464 DOI: 10.1097/JCP.0000000000000217  1
2014 Noorbakhsh F, Baker GB, Power C. Allopregnanolone and neuroinflammation: a focus on multiple sclerosis. Frontiers in Cellular Neuroscience. 8: 134. PMID 24917787 DOI: 10.3389/fncel.2014.00134  1
2014 Haile Y, Fu W, Shi B, Westaway D, Baker G, Jhamandas J, Giuliani F. Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes. Journal of Neuroscience Research. 92: 1187-98. PMID 24801011 DOI: 10.1002/Jnr.23399  1
2014 Matveychuk D, Nunes E, Ullah N, Aldawsari FS, Velázquez-Martínez CA, Baker GB. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 53: 67-73. PMID 24607770 DOI: 10.1016/j.pnpbp.2014.02.011  1
2014 Acharjee S, Branton WG, Vivithanaporn P, Maingat F, Paul AM, Dickie P, Baker GB, Power C. HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors. Brain, Behavior, and Immunity. 40: 74-84. PMID 24607605 DOI: 10.1016/J.Bbi.2014.02.016  1
2014 Cherkasova MV, Faridi N, Casey KF, O'Driscoll GA, Hechtman L, Joober R, Baker GB, Palmer J, Dagher A, Leyton M, Benkelfat C. Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1498-507. PMID 24378745 DOI: 10.1038/Npp.2013.349  1
2014 Casey KF, Benkelfat C, Cherkasova MV, Baker GB, Dagher A, Leyton M. Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction. Biological Psychiatry. 76: 23-30. PMID 24138922 DOI: 10.1016/J.Biopsych.2013.08.033  1
2014 Li Y, Li L, Stephens MJ, Zenner D, Murray KC, Winship IR, Vavrek R, Baker GB, Fouad K, Bennett DJ. Synthesis, transport, and metabolism of serotonin formed from exogenously applied 5-HTP after spinal cord injury in rats. Journal of Neurophysiology. 111: 145-63. PMID 24068759 DOI: 10.1152/Jn.00508.2013  1
2014 Thomas R, Baker G, Dursun S, Todd K, Dhami K, Chue J, Chue P. Glycine reuptake inhibitors in the treatment of negative symptoms of schizophrenia Klinik Psikofarmakoloji Bulteni. 24: 195-200. DOI: 10.5455/Bcp.20140918102748  1
2013 Nunes EA, Rezende TM, Morais SL, Crippa JA, Dursun SM, Baker GB, Hallak JE. Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports. Therapeutic Advances in Psychopharmacology. 3: 83-8. PMID 24167679 DOI: 10.1177/2045125312464995  1
2013 Casey KF, Cherkasova MV, Larcher K, Evans AC, Baker GB, Dagher A, Benkelfat C, Leyton M. Individual differences in frontal cortical thickness correlate with the d-amphetamine-induced striatal dopamine response in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 15285-94. PMID 24048857 DOI: 10.1523/Jneurosci.5029-12.2013  1
2013 Chue PS, Baker GB. Glycine reuptake inhibition: a promising therapeutic strategy in the treatment of schizophrenia? Future Medicinal Chemistry. 5: 1475-7. PMID 24024940 DOI: 10.4155/fmc.13.118  1
2013 Dhami KS, Churchward MA, Baker GB, Todd KG. Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult. Molecular and Cellular Neurosciences. 56: 365-74. PMID 23876875 DOI: 10.1016/J.Mcn.2013.07.006  1
2013 Benson CA, Wong G, Tenorio G, Baker GB, Kerr BJ. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE). Behavioural Brain Research. 252: 302-11. PMID 23777648 DOI: 10.1016/J.Bbr.2013.06.019  1
2013 Hallak JE, Maia-de-Oliveira JP, Abrao J, Evora PR, Zuardi AW, Crippa JA, Belmonte-de-Abreu P, Baker GB, Dursun SM. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. Jama Psychiatry. 70: 668-76. PMID 23699763 DOI: 10.1001/jamapsychiatry.2013.1292  1
2013 Song MS, Matveychuk D, MacKenzie EM, Duchcherer M, Mousseau DD, Baker GB. An update on amine oxidase inhibitors: multifaceted drugs. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 44: 118-24. PMID 23410524 DOI: 10.1016/j.pnpbp.2013.02.001  1
2013 Matveychuk D, Nunes E, Ullah N, Velázquez-Martinez CA, MacKenzie EM, Baker GB. Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 987-96. PMID 23392617 DOI: 10.1007/s00702-013-0978-0  1
2013 Maingat FG, Polyak MJ, Paul AM, Vivithanaporn P, Noorbakhsh F, Ahboucha S, Baker GB, Pearson K, Power C. Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 725-37. PMID 23150523 DOI: 10.1096/Fj.12-215079  1
2013 Revett TJ, Baker GB, Jhamandas J, Kar S. Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. Journal of Psychiatry & Neuroscience : Jpn. 38: 6-23. PMID 22894822 DOI: 10.1503/Jpn.110190  1
2013 Dhami K, MacKay M, Maia-de-Oliveira JP, Hallak J, Todd K, Baker G, Dursun S. Novel targets for development of drugs for treating schizophrenia: Focus on glycine, D-serine and nitric oxide Klinik Psikofarmakoloji Bulteni. 23: 129-137. DOI: 10.5455/bcp.20130629042437  1
2013 Ambrose T, Cullen S, Baker G, Smith M, Elia M, Leach R, Silva AD. PWE-196 Prevalence of Obesity, by Specialty, amongst Inpatients in the South of England Gut. 62. DOI: 10.1136/Gutjnl-2013-304907.484  0.01
2012 Maia-de-Oliveira JP, Trzesniak C, Oliveira IR, Kempton MJ, Rezende TM, Iego S, Baker GB, Dursun SM, Machado-de-Sousa JP, Hallak JE. Nitric oxide plasma/serum levels in patients with schizophrenia: a systematic review and meta-analysis. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 34: S149-55. PMID 23429845 DOI: 10.1016/j.rbp.2012.07.001  1
2012 Nunes EA, Canever L, Oliveira Ld, Luca RD, Quevedo J, Zugno A, Peregrino A, Crippa JA, Dursun SM, Baker GB, Hallak JE. Effects of pregabalin on behavioral alterations induced by ketamine in rats. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 34: 329-33. PMID 23429779 DOI: 10.1016/j.rbp.2012.02.005  1
2012 Chue PS, MacKenzie EM, Chue JA, Baker GB. The pharmacology and formulation of paliperidone extended release. Expert Review of Neurotherapeutics. 12: 1399-410. PMID 23237347 DOI: 10.1586/ern.12.138  1
2012 Mousseau DD, Baker GB. Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain [dys]function? Current Topics in Medicinal Chemistry. 12: 2163-76. PMID 23231394  1
2012 Al-Nuaimi SK, Mackenzie EM, Baker GB. Monoamine oxidase inhibitors and neuroprotection: a review. American Journal of Therapeutics. 19: 436-48. PMID 22960850 DOI: 10.1097/MJT.0b013e31825b9eb5  1
2012 Nunes EA, Freire RC, Dos Reis M, de Oliveira E Silva AC, Machado S, Crippa JA, Dursun SM, Baker GB, Hallak JE, Nardi AE. Sulpiride and refractory panic disorder. Psychopharmacology. 223: 247-9. PMID 22864966 DOI: 10.1007/s00213-012-2818-6  1
2012 Nunes EA, MacKenzie EM, Rossolatos D, Perez-Parada J, Baker GB, Dursun SM. D-serine and schizophrenia: an update. Expert Review of Neurotherapeutics. 12: 801-12. PMID 22853788 DOI: 10.1586/ern.12.65  1
2012 McEwen AM, Burgess DT, Hanstock CC, Seres P, Khalili P, Newman SC, Baker GB, Mitchell ND, Khudabux-Der J, Allen PS, LeMelledo JM. Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2428-35. PMID 22805604 DOI: 10.1038/Npp.2012.101  1
2012 Simpson SM, Hickey AJ, Baker GB, Reynolds JN, Beninger RJ. The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats. Pharmacology, Biochemistry, and Behavior. 102: 109-17. PMID 22503968 DOI: 10.1016/j.pbb.2012.03.027  1
2012 Nunes E, Schneider B, Dursun S, Baker G, Hallak J. Hypoplastic splenium of the corpus callosum and co-occurrence of attention deficit/hyperactivity and language disorders: a case report. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 34: 114-5. PMID 22392398 DOI: 10.1590/S1516-44462012000100019  1
2012 Wei Z, Gabriel GG, Rui L, Cao X, Pennington PR, Chlan-Fourney J, Nazarali AJ, Baker GB, Mousseau DD. Monoamine oxidase-A physically interacts with presenilin-1(M146V) in the mouse cortex. Journal of Alzheimer's Disease : Jad. 28: 403-22. PMID 22045496 DOI: 10.3233/JAD-2011-111241  1
2012 Ahboucha S, Gamrani H, Baker G. GABAergic neurosteroids: the "endogenous benzodiazepines" of acute liver failure. Neurochemistry International. 60: 707-14. PMID 22041164 DOI: 10.1016/J.Neuint.2011.10.003  1
2012 Baker GB, Matveychuk D, MacKenzie EM, Dursun SM, Mousseau DD. Monoamine oxidase inhibitors and neuroprotective mechanisms | Monoamin oksidaz inhibitörleri ve nöroprotektif mekanizmalar Klinik Psikofarmakoloji Bulteni. 22: 293-296. DOI: 10.5455/bcp.20121030014051  1
2011 Burback L, Baker GB, Dursun SM. Annual high-dose vitamin D supplementation does not affect mental well-being in older women. Evidence-Based Mental Health. 14: 103. PMID 22009237 DOI: 10.1136/ebmh.2011.100139  1
2011 Oliveira JP, Lobão B, Machado-de-Sousa JP, Baker GB, Dursun S, Hallak JE. Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 33: 223-4. PMID 21971773 DOI: 10.1590/S1516-44462011000300003  1
2011 Noorbakhsh F, Ellestad KK, Maingat F, Warren KG, Han MH, Steinman L, Baker GB, Power C. Impaired neurosteroid synthesis in multiple sclerosis. Brain : a Journal of Neurology. 134: 2703-21. PMID 21908875 DOI: 10.1093/Brain/Awr200  1
2011 Ramachandraih CT, Subramanyam N, Bar KJ, Baker G, Yeragani VK. Antidepressants: From MAOIs to SSRIs and more. Indian Journal of Psychiatry. 53: 180-2. PMID 21772661 DOI: 10.4103/0019-5545.82567  1
2011 Musgrave T, Benson C, Wong G, Browne I, Tenorio G, Rauw G, Baker GB, Kerr BJ. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Brain, Behavior, and Immunity. 25: 1677-88. PMID 21723939 DOI: 10.1016/J.Bbi.2011.06.011  1
2011 Musgrave T, Tenorio G, Rauw G, Baker GB, Kerr BJ. Tissue concentration changes of amino acids and biogenic amines in the central nervous system of mice with experimental autoimmune encephalomyelitis (EAE). Neurochemistry International. 59: 28-38. PMID 21672584 DOI: 10.1016/J.Neuint.2011.03.020  1
2011 Holt A, Mousseau DD, Baker GB. Special issue: amine oxidases: structures, mechanisms and therapeutic targets. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 977-8. PMID 21667272 DOI: 10.1007/s00702-011-0670-1  1
2011 Hallak JE, Dursun SM, Bosi DC, de Macedo LR, Machado-de-Sousa JP, Abrão J, Crippa JA, McGuire P, Krystal JH, Baker GB, Zuardi AW. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 198-202. PMID 21062637 DOI: 10.1016/J.Pnpbp.2010.11.002  1
2011 Matveychuk D, Dursun SM, Wood PL, Baker GB. Reactive aldehydes and neurodegenerative disorders | Reaktif aldehitler ve nörodejeneratij hastali{dotless}klar Klinik Psikofarmakoloji Bulteni. 21: 277-288. DOI: 10.5455/bcp.19691231040000  1
2010 Al-Nuaimi S, Chaves C, Hallak JE, Baker GB, Dursun S. New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 32: 333-8. PMID 21308251 DOI: 10.1590/S1516-44462010000400003  1
2010 Allman AA, Benkelfat C, Durand F, Sibon I, Dagher A, Leyton M, Baker GB, O'Driscoll GA. Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance. Psychopharmacology. 211: 423-33. PMID 20602089 DOI: 10.1007/s00213-010-1912-x  1
2010 Rauw GA, Grant SL, Labrie V, Roder JC, Antflick JE, Hampson DR, Baker GB. Determination of L-serine-O-phosphate in rat and mouse brain tissue using high-performance liquid chromatography and fluorimetric detection. Analytical Biochemistry. 405: 260-2. PMID 20599655 DOI: 10.1016/J.Ab.2010.06.024  1
2010 Song MS, Baker GB, Dursun SM, Todd KG. The antidepressant phenelzine protects neurons and astrocytes against formaldehyde-induced toxicity. Journal of Neurochemistry. 114: 1405-13. PMID 20557421 DOI: 10.1111/j.1471-4159.2010.06857.x  1
2010 Huxtable AG, Zwicker JD, Alvares TS, Ruangkittisakul A, Fang X, Hahn LB, Posse de Chaves E, Baker GB, Ballanyi K, Funk GD. Glia contribute to the purinergic modulation of inspiratory rhythm-generating networks. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 3947-58. PMID 20237265 DOI: 10.1523/Jneurosci.6027-09.2010  1
2010 Yeragani VK, Tancer M, Chokka P, Baker GB. Arvid Carlsson, and the story of dopamine. Indian Journal of Psychiatry. 52: 87-8. PMID 20174530 DOI: 10.4103/0019-5545.58907  1
2010 Chaves C, de Marque CR, Wichert-Ana L, Maia-de-Oliveira JP, Itikawa EN, Crippa JA, Zuardi AW, Todd KG, Baker GB, Dursun SM, Hallak JE. Functional neuroimaging of minocycline's effect in a patient with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 550-2. PMID 20138948 DOI: 10.1016/j.pnpbp.2010.01.020  1
2010 Mitchell ND, Baker GB. An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatrica Scandinavica. 122: 192-210. PMID 20105149 DOI: 10.1111/j.1600-0447.2009.01529.x  1
2010 Noorbakhsh F, Ramachandran R, Barsby N, Ellestad KK, LeBlanc A, Dickie P, Baker G, Hollenberg MD, Cohen EA, Power C. MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 1799-812. PMID 20097875 DOI: 10.1096/Fj.09-147819  1
2010 Antflick JE, Baker GB, Hampson DR. The effects of a low protein diet on amino acids and enzymes in the serine synthesis pathway in mice. Amino Acids. 39: 145-53. PMID 19921396 DOI: 10.1007/s00726-009-0387-8  1
2010 Labrie V, Wang W, Barger SW, Baker GB, Roder JC. Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice. Genes, Brain, and Behavior. 9: 11-25. PMID 19751394 DOI: 10.1111/J.1601-183X.2009.00529.X  1
2010 Kabogo D, Rauw G, Amritraj A, Baker G, Kar S. β-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices Neurobiology of Aging. 31: 1164-1172. PMID 18819729 DOI: 10.1016/J.Neurobiolaging.2008.08.009  1
2009 Antflick JE, Vetiska S, Baizer JS, Yao Y, Baker GB, Hampson DR. L-Serine-O-phosphate in the central nervous system. Brain Research. 1300: 1-13. PMID 19747453 DOI: 10.1016/J.Brainres.2009.08.087  1
2009 Butterworth RF, Lalonde R, Power C, Baker GB, Gamrani H, Ahboucha S. Dehydroepiandrosterone sulphate improves cholestasis-associated fatigue in bile duct ligated rats. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 21: 1319-25. PMID 19594690 DOI: 10.1111/j.1365-2982.2009.01356.x  1
2009 Maingat F, Vivithanaporn P, Zhu Y, Taylor A, Baker G, Pearson K, Power C. Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8429-37. PMID 19571133 DOI: 10.1523/Jneurosci.5818-08.2009  1
2009 Labrie V, Fukumura R, Rastogi A, Fick LJ, Wang W, Boutros PC, Kennedy JL, Semeralul MO, Lee FH, Baker GB, Belsham DD, Barger SW, Gondo Y, Wong AH, Roder JC. Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Human Molecular Genetics. 18: 3227-43. PMID 19483194 DOI: 10.1093/Hmg/Ddp261  1
2009 Krebs-Kraft DL, Rauw G, Baker GB, Parent MB. Zero net flux estimates of septal extracellular glucose levels and the effects of glucose on septal extracellular GABA levels. European Journal of Pharmacology. 611: 44-52. PMID 19345207 DOI: 10.1016/j.ejphar.2009.03.055  1
2009 Labrie V, Duffy S, Wang W, Barger SW, Baker GB, Roder JC. Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice. Learning & Memory (Cold Spring Harbor, N.Y.). 16: 28-37. PMID 19117914 DOI: 10.1101/Lm.1112209  1
2009 Melledo JL, Mailo K, Lara N, Abadia M, Gil L, Ameringen MV, Baker G, Perez-Parada J. Paroxetine-induced increase in LDL cholesterol levels Journal of Psychopharmacology. 23: 826-830. PMID 19074543 DOI: 10.1177/0269881108094320  1
2008 Todd KG, Baker GB. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, Sociã©Tã© Canadienne Des Sciences Pharmaceutiques. 11: 14s-21s. PMID 19203467 DOI: 10.18433/J34S38  1
2008 Song MS, Rauw G, Baker GB, Kar S. Memantine protects rat cortical cultured neurons against β-amyloid-induced toxicity by attenuating tau phosphorylation European Journal of Neuroscience. 28: 1989-2002. PMID 19046381 DOI: 10.1111/J.1460-9568.2008.06498.X  1
2008 McDonald GR, Hudson AL, Dunn SM, You H, Baker GB, Whittal RM, Martin JW, Jha A, Edmondson DE, Holt A. Bioactive contaminants leach from disposable laboratory plasticware. Science (New York, N.Y.). 322: 917. PMID 18988846 DOI: 10.1126/Science.1162395  1
2008 MacKenzie EM, Fassihi A, Davood A, Chen QH, Rauw G, Rauw G, Knaus EE, Baker GB. N-Propynyl analogs of beta-phenylethylidenehydrazines: synthesis and evaluation of effects on glycine, GABA, and monoamine oxidase. Bioorganic & Medicinal Chemistry. 16: 8254-63. PMID 18693021 DOI: 10.1016/J.Bmc.2008.07.027  1
2008 Cangelosi JJ, Prieto VG, Baker GF, Moore BA, Diwan AH. Unusual presentation of multiple epithelioid cell histiocytomas. The American Journal of Dermatopathology. 30: 373-6. PMID 18645309 DOI: 10.1097/DAD.0b013e31817330e9  1
2008 Urichuk L, Prior TI, Dursun S, Baker G. Metabolism of atypical antipsychotics: Involvement of cytochrome P450 enzymes and relevance for drug-drug interactions Current Drug Metabolism. 9: 410-418. PMID 18537577 DOI: 10.2174/138920008784746373  1
2008 Natesan S, Reckless GE, Barlow KBL, Odontiadis J, Nobrega JN, Baker GB, George SR, Mamo D, Kapur S. The antipsychotic potential of l-stepholidine - A naturally occurring dopamine receptor D1 agonist and D2 antagonist Psychopharmacology. 199: 275-289. PMID 18521575 DOI: 10.1007/S00213-008-1172-1  1
2008 Nugent R, Bates J, Baker G, Hogan R, Halverson P, Himstedt L, Just E, Bolick J, Planey B, Jones M, Dillaha J, Brech R. Expanded newborn screening in Arkansas: a program of the Arkansas Department of Health. The Journal of the Arkansas Medical Society. 104: 262-4. PMID 18500040  0.01
2008 Ahboucha S, Jiang W, Chatauret N, Mamer O, Baker GB, Butterworth RF. Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 20: 949-57. PMID 18482252 DOI: 10.1111/j.1365-2982.2008.01132.x  1
2008 Ahboucha S, Butterworth RF, Pomier-Layrargues G, Vincent C, Hassoun Z, Baker GB. Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 20: 671-9. PMID 18282171 DOI: 10.1111/j.1365-2982.2007.01080.x  1
2008 Sibon I, Benkelfat C, Gravel P, Aznavour N, Costes N, Mzengeza S, Booij L, Baker G, Soucy JP, Zimmer L, Descarries L. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biological Psychiatry. 63: 1135-40. PMID 18191817 DOI: 10.1016/J.Biopsych.2007.11.016  1
2008 Batra NA, Seres-Mailo J, Hanstock C, Seres P, Khudabux J, Bellavance F, Baker G, Allen P, Tibbo P, Hui E, Le Melledo JM. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biological Psychiatry. 63: 1178-84. PMID 18061146 DOI: 10.1016/J.Biopsych.2007.10.007  1
2008 MacKenzie EM, Grant SL, Baker GB, Wood PL. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition Neurochemical Research. 33: 430-436. PMID 17768678 DOI: 10.1007/s11064-007-9448-0  1
2008 Ahboucha S, Pomier-Layrargues G, Vincent C, Hassoun Z, Tamaz R, Baker G, Butterworth RF. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis. Neurochemistry International. 52: 569-74. PMID 17669554 DOI: 10.1016/J.Neuint.2007.06.002  1
2007 Baker GB, Sowa B, Todd KG. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? Journal of Psychiatry & Neuroscience : Jpn. 32: 313-5. PMID 17823646  1
2007 Schimanski LA, Ali DW, Baker GB, Nguyen PV. Impaired hippocampal LTP in inbred mouse strains can be rescued by beta-adrenergic receptor activation. The European Journal of Neuroscience. 25: 1589-98. PMID 17425584 DOI: 10.1111/J.1460-9568.2007.05376.X  1
2007 Leyton M, aan het Rot M, Booij L, Baker GB, Young SN, Benkelfat C. Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. Journal of Psychiatry & Neuroscience : Jpn. 32: 129-36. PMID 17353942  1
2007 MacKenzie EM, Odontiadis J, Le Mellédo JM, Prior TI, Baker GB. The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders Cellular and Molecular Neurobiology. 27: 541-574. PMID 17235696 DOI: 10.1007/s10571-006-9086-0  1
2007 Odontiadis J, MacKenzie EM, Natesan S, Mamo D, Kapur S, Baker GB. Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 850: 544-547. PMID 17161981 DOI: 10.1016/j.jchromb.2006.11.039  1
2007 Rittenbach KA, Holt A, Ling L, Shan J, Baker GB. Metabolism of N-methyl, N-propargylphenylethylamine: studies with human liver microsomes and cDNA expressed cytochrome P450 (CYP) enzymes. Cellular and Molecular Neurobiology. 27: 179-90. PMID 17160483 DOI: 10.1007/s10571-006-9085-1  1
2006 Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Archives of General Psychiatry. 63: 1386-95. PMID 17146013 DOI: 10.1001/Archpsyc.63.12.1386  1
2006 Shulman Y, Grant S, Seres P, Hanstock C, Baker G, Tibbo P. The relation between peripheral and central glutamate and glutamine in healthy male volunteers. Journal of Psychiatry & Neuroscience : Jpn. 31: 406-10. PMID 17136218  1
2006 Wood PL, Khan MA, Moskal JR, Todd KG, Tanay VA, Baker G. Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Research. 1122: 184-90. PMID 17026969 DOI: 10.1016/J.Brainres.2006.09.003  1
2006 Grant SL, Shulman Y, Tibbo P, Hampson DR, Baker GB. Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 844: 278-82. PMID 16890503 DOI: 10.1016/J.Jchromb.2006.07.022  1
2006 Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: Meta-analysis British Medical Journal. 332: 385-388. PMID 16473858 DOI: 10.1136/Bmj.38731.532766.F6  1
2006 Chrapko W, Jurasz P, Radomski MW, Archer SL, Newman SC, Baker G, Lara N, Le Mellédo JM. Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1286-93. PMID 16319917 DOI: 10.1038/Sj.Npp.1300961  1
2005 Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S. The efficacy and safety of exogenous melatonin for primary sleep disorders: A meta-analysis Journal of General Internal Medicine. 20: 1151-1158. PMID 16423108 DOI: 10.1111/J.1525-1497.2005.0243.X  1
2005 Jindal R, MacKenzie EM, Baker GB, Yeragani VK. Cardiac risk and schizophrenia Journal of Psychiatry and Neuroscience. 30: 393-395. PMID 16327872  1
2005 Rittenbach K, Sloley BD, Ling L, Coutts RT, Shan J, Baker GB. A rapid, sensitive electron-capture gas chromatographic procedure for analysis of metabolites of N-methyl,N-propargylphenylethylamine, a potential neuroprotective agent Journal of Pharmacological and Toxicological Methods. 52: 373-378. PMID 16087356 DOI: 10.1016/j.vascn.2005.07.001  1
2005 Redrobe JP, Dumont Y, Fournier A, Baker GB, Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides. 26: 1394-400. PMID 16042979 DOI: 10.1016/J.Peptides.2005.03.029  1
2005 Sowa B, Rauw G, Davood A, Fassihi A, Knaus EE, Baker GB. Design and biological evaluation of phenyl-substituted analogs of beta-phenylethylidenehydrazine. Bioorganic & Medicinal Chemistry. 13: 4389-95. PMID 15927473 DOI: 10.1016/J.Bmc.2005.04.072  1
2005 Vartazarmian R, Malik S, Baker GB, Boksa P. Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring Psychopharmacology. 178: 328-338. PMID 15365684 DOI: 10.1007/S00213-004-2003-7  1
2004 Le Mellédo JM, Baker GB. Role of progesterone and other neuroactive steroids in anxiety disorders Expert Review of Neurotherapeutics. 4: 851-860. PMID 15853511 DOI: 10.1586/14737175.4.5.851  1
2004 Le Mellédo JM, Mahil N, Baker GB. Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder? Journal of Psychiatry and Neuroscience. 29: 414-416. PMID 15644982  1
2004 Sowa BN, Holt A, Todd KG, Baker GB. Monoamine oxidase inhibitors, their structural analogues, and neuroprotection. Indian Journal of Experimental Biology. 42: 851-7. PMID 15462176  1
2004 Holt A, Wieland B, Baker GB. Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands. British Journal of Pharmacology. 143: 495-507. PMID 15451775 DOI: 10.1038/sj.bjp.0705986  1
2004 Clements RL, Holt A, Gordon ES, Todd KG, Baker GB. Determination of rat hepatic polyamines by electron-capture gas chromatography. Journal of Pharmacological and Toxicological Methods. 50: 35-9. PMID 15233965 DOI: 10.1016/j.vascn.2003.12.001  1
2004 Salsali M, Holt A, Baker GB. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. Cellular and Molecular Neurobiology. 24: 63-76. PMID 15049511 DOI: 10.1023/B:Cemn.0000012725.31108.4A  1
2004 Fletcher PJ, Sinyard J, Salsali M, Baker GB. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Psychopharmacology. 174: 406-13. PMID 14740149 DOI: 10.1007/S00213-003-1747-9  1
2004 Bell EC, Baker GB, Poag C, Bellavance F, Khudabux J, Le Mellédo JM. Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females Psychopharmacology. 172: 248-254. PMID 14712334 DOI: 10.1007/s00213-003-1660-2  1
2004 Leyton M, Dagher A, Boileau I, Casey K, Baker GB, Diksic M, Gunn R, Young SN, Benkelfat C. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 427-32. PMID 14583741 DOI: 10.1038/Sj.Npp.1300328  1
2004 Sowa BN, Todd KG, Tanay VAMI, Holt A, Baker GB. Amine oxidase inhibitors and development of neuroprotective drugs Current Neuropharmacology. 2: 153-168. DOI: 10.2174/1570159043476800  1
2003 Holt A, Todd KG, Baker GB. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain. Annals of the New York Academy of Sciences. 1009: 309-22. PMID 15028605 DOI: 10.1196/annals.1304.040  1
2003 Lara N, Baker GB, Archer SL, Le Mellédo JM. Increased cholesterol levels during paroxetine administration in healthy men Journal of Clinical Psychiatry. 64: 1455-1459. PMID 14728107 DOI: 10.4088/Jcp.V64N1209  1
2003 Lara N, Archer SL, Baker GB, Le Mellédo JM. Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide Journal of Clinical Psychopharmacology. 23: 641-645. PMID 14624192 DOI: 10.1097/01.Jcp.0000085416.08426.1D  1
2003 Asghar SJ, Tanay VAMI, Baker GB, Greenshaw A, Silverstone PH. Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers Human Psychopharmacology. 18: 291-299. PMID 12766934 DOI: 10.1002/hup.480  1
2003 Shiah IS, Yatham LN, Gau YC, Baker GB. Effect of lamotrigine on plasma GABA levels in healthy humans Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27: 419-423. PMID 12691776 DOI: 10.1016/S0278-5846(03)00028-9  1
2002 Baker GB, Prior TI. Stereochemistry and drug efficacy and development: Relevance of chirality to antidepressant and antipsychotic drugs Annals of Medicine. 34: 537-543. PMID 12553493 DOI: 10.1080/078538902321117742  1
2002 Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 1027-35. PMID 12464459 DOI: 10.1016/S0893-133X(02)00366-4  1
2002 Mejia JM, Ervin FR, Baker GB, Palmour RM. Monoamine oxidase inhibition during brain development induces pathological aggressive behavior in mice Biological Psychiatry. 52: 811-822. PMID 12372653 DOI: 10.1016/S0006-3223(02)01418-X  1
2002 Fletcher PJ, Korth KM, Robinson SR, Baker GB. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology. 162: 282-91. PMID 12122486 DOI: 10.1007/S00213-002-1104-4  1
2002 Kapur S, McClelland RA, VanderSpek SC, Wadenberg ML, Baker G, Nobrega J, Zipursky RB, Seeman P. Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action. Neuroreport. 13: 831-5. PMID 11997696 DOI: 10.1097/00001756-200205070-00019  1
2002 Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. The Journal of Clinical Psychiatry. 63: 181-6. PMID 11926715 DOI: 10.4088/Jcp.V63N0302  1
2002 Rotzinger S, Baker GB. Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes European Neuropsychopharmacology. 12: 91-100. PMID 11872324 DOI: 10.1016/S0924-977X(02)00005-6  1
2002 Parent MB, Master S, Kashlub S, Baker GB. Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum. Biochemical Pharmacology. 63: 57-64. PMID 11754874 DOI: 10.1016/S0006-2952(01)00856-5  1
2001 Asghar SJ, Baker GB, Rauw GA, Silverstone PH. A rapid method of determining amphetamine in plasma samples using pentafluorobenzenesulfonyl chloride and electron-capture gas chromatography Journal of Pharmacological and Toxicological Methods. 46: 111-115. PMID 12481848 DOI: 10.1016/S1056-8719(02)00167-3  1
2001 Zedkova L, Rauw GA, Baker GB, Coupland NJ. A rapid high-pressure liquid chromatographic procedure for determination of flumazenil in plasma Journal of Pharmacological and Toxicological Methods. 46: 57-60. PMID 12164261 DOI: 10.1016/S1056-8719(01)00162-9  1
2001 Tanay VA, Parent MB, Wong JT, Paslawski T, Martin IL, Baker GB. Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain. Cellular and Molecular Neurobiology. 21: 325-39. PMID 11775064 DOI: 10.1023/A:1012697904299  1
2001 Ling L, Urichuk LJ, Sloley BD, Coutts RT, Baker GB, Shan JJ, Pang PKT. Synthesis of N-propargylphenelzine and analogues as neuroprotective agents Bioorganic and Medicinal Chemistry Letters. 11: 2715-2717. PMID 11591508 DOI: 10.1016/S0960-894X(01)00549-2  1
2001 Tanay VM, Greenshaw AJ, Baker GB, Bateson AN. Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression. Molecular Psychiatry. 6: 404-12. PMID 11443524 DOI: 10.1038/Sj.Mp.4000879  1
2001 Parent M, Bush D, Rauw G, Master S, Vaccarino F, Baker G. Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis. Methods (San Diego, Calif.). 23: 11-20. PMID 11162146 DOI: 10.1006/Meth.2000.1102  1
2001 Shuaib A, Todd KG, Baker GB. In vivo microdialysis. Methods (San Diego, Calif.). 23: 1-2. PMID 11162144 DOI: 10.1006/meth.2000.1100  1
2001 Lai CT, Gordon ES, Kennedy SH, Bateson AN, Coutts RT, Baker GB. Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection Journal of Chromatography B: Biomedical Sciences and Applications. 749: 275-279. PMID 11145064 DOI: 10.1016/S0378-4347(00)00389-3  1
2001 Sloley B, Urichuk LJ, Lei L, Coutts RT, Baker GB, Shan JJ, Pang PKT. Monoamine oxidase inhibition and neuroprotection by N1-propargylphenelzine Drug Development Research. 53: 15-21. DOI: 10.1002/ddr.1164  1
2000 Salsali M, Coutts RT, Baker GB. A rapid electron-capture gas chromatographic procedure for the analysis of p-hydroxymephenytoin Journal of Pharmacological and Toxicological Methods. 44: 461-465. PMID 11395323 DOI: 10.1016/S1056-8719(01)00113-7  1
2000 Sherry RL, Rauw G, McKenna KF, Paetsch PR, Coutts RT, Baker GB. Failure to detect amphetamine or 1-amino-3-phenlypropane in humans or rats receiving the MAO inhibitor tranylcypromine Journal of Affective Disorders. 61: 23-29. PMID 11099737 DOI: 10.1016/S0165-0327(99)00188-3  1
2000 Shiah IS, Yatham LN, Baker GB. Divalproex sodium increases plasma GABA levels in healthy volunteers International Clinical Psychopharmacology. 15: 221-225. PMID 10954062 DOI: 10.1097/00004850-200015040-00005  1
2000 Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ. Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction. Behavioural Pharmacology. 11: 109-16. PMID 10877115 DOI: 10.1097/00008877-200004000-00002  1
2000 Urichuk LJ, Allison K, Holt A, Greenshaw AJ, Baker GB. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration. Journal of Affective Disorders. 58: 135-44. PMID 10781703 DOI: 10.1016/S0165-0327(99)00105-6  1
2000 Parent MB, Habib MK, Baker GB. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine. Biochemical Pharmacology. 59: 1253-63. PMID 10736426 DOI: 10.1016/S0006-2952(00)00244-6  1
2000 Hascoët M, Bourin M, Colombel MC, Fiocco AJ, Baker GB. Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice Pharmacology Biochemistry and Behavior. 65: 339-344. PMID 10672988 DOI: 10.1016/S0091-3057(99)00191-4  1
2000 Leyton M, Young SN, Pihl RO, Etezadi S, Lauze C, Blier P, Baker GB, Benkelfat C. Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 52-63. PMID 10633491 DOI: 10.1016/S0893-133X(99)00086-X  1
1999 Salsali M, Coutts RT, Baker GB. Analysis of dextrorphan, a metabolite of dextromethorphan, using gas chromatography with electron-capture detection Journal of Pharmacological and Toxicological Methods. 41: 143-146. PMID 10691018 DOI: 10.1016/S1056-8719(99)00033-7  1
1999 Prior TI, Chue PS, Tibbo P, Baker GB. Drug metabolism and atypical antipsychotics European Neuropsychopharmacology. 9: 301-309. PMID 10422890 DOI: 10.1016/S0924-977X(98)00040-6  1
1999 Rotzinger S, Bourin M, Akimoto Y, Coutts RT, Baker GB. Metabolism of some 'second'- and 'fourth'-generation antidepressants: Iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine Cellular and Molecular Neurobiology. 19: 427-442. PMID 10379419 DOI: 10.1023/A:1006953923305  1
1999 Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin. Psychopharmacology. 143: 426-32. PMID 10367561 DOI: 10.1007/S002130050968  1
1999 Baker GB, Urichuk LJ, McKenna KF, Kennedy SH. Metabolism of monoamine oxidase inhibitors Cellular and Molecular Neurobiology. 19: 411-426. PMID 10319194 DOI: 10.1023/A:1006901900106  1
1999 Lane RM, Baker GB. Chirality and drugs used in psychiatry: Nice to know or need to know? Cellular and Molecular Neurobiology. 19: 355-372. PMID 10319192 DOI: 10.1023/A:1006997731966  1
1999 Baker GB. Drug metabolism and psychiatry: Preface Cellular and Molecular Neurobiology. 19: 301-308. PMID 10319189 DOI: 10.1023/A:1006941614219  1
1999 Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ. Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction. Psychopharmacology. 141: 421-7. PMID 10090650 DOI: 10.1007/S002130050852  1
1999 Hegadoren KM, Baker GB, Bourin M. 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans Neuroscience and Biobehavioral Reviews. 23: 539-553. PMID 10073892 DOI: 10.1016/S0149-7634(98)00046-3  1
1999 Fang J, Bourin M, Baker GB. Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4 Naunyn-Schmiedeberg's Archives of Pharmacology. 359: 147-151. PMID 10048600 DOI: 10.1007/PL00005334  1
1999 Dimmock JR, Puthucode RN, Tuchek J, Baker GB, Hinko CN, Steinmiller CL, Stables JP. Anticonvulsant activities of 4,(4'-fluorophenoxy) benzaldehyde semicarbazone Drug Development Research. 46: 112-125. DOI: 10.1002/(SICI)1098-2299(199902)46:2<112::AID-DDR4>3.0.CO;2-N  1
1998 Palmour RM, Ervin FR, Baker GB, Young SN. An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology. 136: 1-7. PMID 9537676 DOI: 10.1007/S002130050532  1
1998 Lai CT, Tanay VAMI, Charrois GJR, Baker GB, Bateson AN. Effects of phenelzine and imipramine on the steady-state levels of mRNAs that encode glutamic acid decarboxylase (GAD67 and GAD65), the GABA transporter GAT-1 and GABA transaminase in rat cortex Naunyn-Schmiedeberg's Archives of Pharmacology. 357: 32-38. PMID 9459570 DOI: 10.1007/PL00005135  1
1997 Lai CT, Tanay VA, Rauw GA, Bateson AN, Martin IL, Baker GB. Rapid, sensitive procedure to determine buspirone levels in rat brains using gas chromatography with nitrogen-phosphorus detection. Journal of Chromatography. B, Biomedical Sciences and Applications. 704: 175-9. PMID 9518147 DOI: 10.1016/S0378-4347(97)00434-9  1
1997 Vanderwolf CH, McLauchlin M, Dringenberg HC, Baker GB. Brain structures involved in the behavioral stimulant effect of central serotonin release. Brain Research. 772: 121-34. PMID 9406964 DOI: 10.1016/S0006-8993(97)00870-6  1
1997 Urichuk LJ, Aspeslet LJ, Holt A, Silverstone PH, Coutts RT, Baker GB. Determination of p-trifluoromethylphenol, a metabolite of fluoxetine, in tissues and body fluids using an electron-capture gas chromatographic procedure. Journal of Chromatography. B, Biomedical Sciences and Applications. 698: 103-9. PMID 9367198 DOI: 10.1016/S0378-4347(97)00304-6  1
1997 Rotzinger S, Todd KG, Bourin M, Coutts RT, Baker GB. A rapid electron-capture gas chromatographic method for the quantification of fluvoxamine in brain tissue. Journal of Pharmacological and Toxicological Methods. 37: 129-33. PMID 9253748 DOI: 10.1016/S1056-8719(97)00008-7  1
1997 de Groot CM, Yeates KO, Baker GB, Bornstein RA. Impaired neuropsychological functioning in Tourette's syndrome subjects with co-occurring obsessive-compulsive and attention deficit symptoms. The Journal of Neuropsychiatry and Clinical Neurosciences. 9: 267-72. PMID 9144107 DOI: 10.1176/jnp.9.2.267  1
1997 Mousseau DD, Baker GB, Butterworth RF. Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. Journal of Neurochemistry. 68: 1200-8. PMID 9048767 DOI: 10.1046/J.1471-4159.1997.68031200.X  1
1997 Holt A, Sharman DF, Baker GB, Palcic MM. A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Analytical Biochemistry. 244: 384-92. PMID 9025956 DOI: 10.1006/abio.1996.9911  1
1996 Tanay VA, Glencorse TA, Greenshaw AJ, Baker GB, Bateson AN. Chronic administration of antipanic drugs alters rat brainstem GABAA receptor subunit mRNA levels. Neuropharmacology. 35: 1475-82. PMID 9014163 DOI: 10.1016/S0028-3908(96)00065-2  1
1996 Taber MT, Baker GB, Fibiger HC. Glutamate receptor agonists decrease extracellular dopamine in the rat nucleus accumbens in vivo. Synapse (New York, N.Y.). 24: 165-72. PMID 8890458 DOI: 10.1002/(Sici)1098-2396(199610)24:2<165::Aid-Syn8>3.0.Co;2-D  1
1996 Paslawski T, Treit D, Baker GB, George M, Coutts RT. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology. 127: 19-24. PMID 8880939 DOI: 10.1007/Bf02805970  1
1996 Vanderwolf CH, Baker GB. The role of brain noradrenaline in cortical activation and behavior: a study of lesions of the locus coeruleus, medial thalamus and hippocampus-neocortex and of muscarinic blockade in the rat. Behavioural Brain Research. 78: 225-34. PMID 8864055 DOI: 10.1016/0166-4328(95)00253-7  1
1996 McGregor A, Baker G, Roberts DC. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Pharmacology, Biochemistry, and Behavior. 53: 5-9. PMID 8848459 DOI: 10.1016/0091-3057(95)00192-1  1
1996 Dringenberg HC, Baker GB, Urichuk LJ, Vanderwolf CH. Anti-serotonergic effects of urethane and chloral hydrate may not be mediated by a blockade of 5-HT2 receptors. Short communication. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 693-8. PMID 8836931 DOI: 10.1007/BF01271229  1
1996 Holt A, Baker GB. Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine. Naunyn-Schmiedeberg's Archives of Pharmacology. 354: 17-24. PMID 8832583 DOI: 10.1007/BF00168701  1
1996 Wang L, Morin KW, Kumar R, Cheraghali M, Todd KG, Baker GB, Knaus EE, Wiebe LI. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine. Journal of Medicinal Chemistry. 39: 826-33. PMID 8632406 DOI: 10.1021/Jm9408326  1
1995 Todd KG, Baker GB. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline. Journal of Affective Disorders. 35: 125-9. PMID 8749840 DOI: 10.1016/0165-0327(95)00056-9  1
1995 Holt A, Baker GB. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Progress in Brain Research. 106: 187-97. PMID 8584654 DOI: 10.1016/S0079-6123(08)61215-7  1
1995 Todd KG, McManus DJ, Baker GB. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain. Cellular and Molecular Neurobiology. 15: 361-70. PMID 7553735 DOI: 10.1007/BF02089946  1
1995 Dringenberg HC, Hargreaves EL, Baker GB, Cooley RK, Vanderwolf CH. p-chlorophenylalanine-induced serotonin depletion: reduction in exploratory locomotion but no obvious sensory-motor deficits. Behavioural Brain Research. 68: 229-37. PMID 7544584 DOI: 10.1016/0166-4328(94)00174-E  1
1994 Goodnough DB, Baker GB, Mousseau DD, Greenshaw AJ, Dewhurst WG. Effects of low- and high-dose tranylcypromine on [3H]tryptamine binding sites in the rat hippocampus and striatum. Neurochemical Research. 19: 5-8. PMID 8139763 DOI: 10.1007/Bf00966720  1
1994 McGregor A, Baker G, Roberts DC. Effect of 6-hydroxydopamine lesions of the amygdala on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Brain Research. 646: 273-8. PMID 8069674 DOI: 10.1016/0006-8993(94)90089-2  1
1994 Baker GB, Coutts RT, Holt A. Derivatization with acetic anhydride: applications to the analysis of biogenic amines and psychiatric drugs by gas chromatography and mass spectrometry. Journal of Pharmacological and Toxicological Methods. 31: 141-8. PMID 8068975 DOI: 10.1016/1056-8719(94)90076-0  1
1994 Baker GB, Coutts RT, Holt A. Metabolism and chirality in psychopharmacology. Biological Psychiatry. 36: 211-3. PMID 7986884 DOI: 10.1016/0006-3223(94)90601-7  1
1994 Sherry-McKenna RL, Wong JT, Paetsch PR, Baker GB, Mousseau DD, McKenna KF, Coutts RT, Greenshaw AJ. Monoamine oxidase inhibitors: effects on tryptophan concentrations in rat brain. Journal of Neural Transmission. Supplementum. 41: 155-63. PMID 7931222 DOI: 10.1007/978-3-7091-9324-2_22  1
1994 McKenna KF, McManus DJ, Baker GB, Coutts RT. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function. Journal of Neural Transmission. Supplementum. 41: 115-22. PMID 7931216 DOI: 10.1007/978-3-7091-9324-2_15  1
1994 Roberts DC, Loh EA, Baker GB, Vickers G. Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacology, Biochemistry, and Behavior. 49: 177-82. PMID 7816870 DOI: 10.1016/0091-3057(94)90473-1  1
1993 Baker GB, Bornstein RA, Douglass AB, Van Muyden JC, Ashton S, Bazylewich TL. Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 18: 173-8. PMID 8466590 DOI: 10.1007/BF03160031  1
1993 Mousseau DD, McManus DJ, Baker GB, Juorio AV, Dewhurst WG, Greenshaw AJ. Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes. Cellular and Molecular Neurobiology. 13: 3-13. PMID 8384528 DOI: 10.1007/Bf00712985  1
1993 Paetsch PR, Baker GB, Greenshaw AJ. Induction of functional down-regulation of beta-adrenoceptors in rats by 2-phenylethylamine. Journal of Pharmaceutical Sciences. 82: 22-4. PMID 8381487 DOI: 10.1002/Jps.2600820105  1
1993 Allison K, Paetsch PR, Baker GB, Greenshaw AJ. Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding. European Journal of Pharmacology. 249: 125-31. PMID 8287894 DOI: 10.1016/0014-2999(93)90424-G  1
1993 Yamada N, Takahashi S, Todd KG, Baker GB, Paetsch PR. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain. Journal of Pharmaceutical Sciences. 82: 934-7. PMID 7901387 DOI: 10.1002/jps.2600820912  1
1992 McManus DJ, Baker GB, Martin IL, Greenshaw AJ, McKenna KF. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. Biochemical Pharmacology. 43: 2486-9. PMID 1610412 DOI: 10.1016/0006-2952(92)90331-C  1
1992 Paetsch PR, Baker GB, Caffaro LE, Greenshaw AJ, Rauw GA, Coutts RT. Electron-capture gas chromatographic procedure for simultaneous determination of amphetamine and N-methylamphetamine. Journal of Chromatography. 573: 313-7. PMID 1601966 DOI: 10.1016/0378-4347(92)80135-D  1
1992 McKenna KF, Baker GB, Coutts RT, Greenshaw AJ. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. Journal of Pharmaceutical Sciences. 81: 832-5. PMID 1383493 DOI: 10.1002/Jps.2600810823  1
1991 Baker GB, Bornstein RA, Rouget AC, Ashton SE, van Muyden JC, Coutts RT. Phenylethylaminergic mechanisms in attention-deficit disorder. Biological Psychiatry. 29: 15-22. PMID 2001444 DOI: 10.1016/0006-3223(91)90207-3  1
1991 Robertson B, Baker GB, Vanderwolf CH. The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior. Brain Research. 555: 265-75. PMID 1933339 DOI: 10.1016/0006-8993(91)90351-U  1
1991 Baker GB, Wong JT, Yeung JM, Coutts RT. Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). Journal of Affective Disorders. 21: 207-11. PMID 1648582 DOI: 10.1016/0165-0327(91)90041-P  1
1990 Wong JT, Paetsch PR, Baker GB, Greenshaw AJ, Coutts RT. A rapid procedure for the analysis of phenylalanine in brain tissue utilizing electron-capture gas chromatography. Journal of Neuroscience Methods. 32: 105-9. PMID 2366572 DOI: 10.1016/0165-0270(90)90165-C  1
1990 Vanderwolf CH, Baker GB, Dickson C. Serotonergic control of cerebral activity and behavior: models of dementia. Annals of the New York Academy of Sciences. 600: 366-82; discussion 3. PMID 2252321 DOI: 10.1111/j.1749-6632.1990.tb16895.x  1
1990 Bornstein RA, Baker GB, Carroll A, King G, Wong JT, Douglass AB. Plasma amino acids in attention deficit disorder. Psychiatry Research. 33: 301-6. PMID 2243904 DOI: 10.1016/0165-1781(90)90046-8  1
1990 Wong JT, Baker GB, Coutts RT, Dewhurst WG. Long-lasting elevation of alanine in brain produced by the antidepressant phenelzine. Brain Research Bulletin. 25: 179-81. PMID 2207706 DOI: 10.1016/0361-9230(90)90272-2  1
1990 Vanderwolf CH, Dickson CT, Baker GB. Effects of p-chlorophenylalanine and scopolamine on retention of habits in rats. Pharmacology, Biochemistry, and Behavior. 35: 847-53. PMID 2140608 DOI: 10.1016/0091-3057(90)90369-S  1
1989 Vanderwolf CH, Leung LW, Baker GB, Stewart DJ. The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine. Brain Research. 504: 181-91. PMID 2598021 DOI: 10.1016/0006-8993(89)91355-3  1
1989 Baker GB, Greenshaw AJ. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cellular and Molecular Neurobiology. 9: 1-44. PMID 2565769 DOI: 10.1007/BF00711441  1
1989 Greenshaw AJ, Rao TS, Nazarali AJ, Baker GB, Coutts RT. Chronic effects of tranylcypromine and 4-fluorotranylcypromine on regional brain monoamine metabolism in rats: a comparison with clorgyline. Biological Psychiatry. 25: 1014-20. PMID 2470425 DOI: 10.1016/0006-3223(89)90289-8  1
1988 Danielson TJ, Coutts RT, Baker GB, Chan MC. Potential prodrugs of phenelzine: N2-Acetylphenelzine and N2-ethoxycarbonylphenelzine Journal of Pharmaceutical Sciences. 77: 498-499. PMID 3171928 DOI: 10.1002/jps.2600770607  1
1988 Wong JT, Baker GB, Coutts RT. Rapid and simple procedure for the determination of urinary phenylacetic acid using derivatization in aqueous medium followed by electron-capture gas chromatography. Journal of Chromatography. 428: 140-6. PMID 3170666 DOI: 10.1016/S0378-4347(00)83898-0  1
1988 Greenshaw AJ, Nazarali AJ, Rao TS, Baker GB, Coutts RT. Chronic tranylcypromine treatment induces functional alpha 2-adrenoceptor down-regulation in rats. European Journal of Pharmacology. 154: 67-72. PMID 2846327 DOI: 10.1016/0014-2999(88)90364-0  1
1987 Baker GB, Wong JT, Coutts RT, Pasutto FM. Simultaneous extraction and quantitation of several bioactive amines in cheese and chocolate. Journal of Chromatography. 392: 317-31. PMID 3597580 DOI: 10.1016/S0021-9673(01)94276-1  1
1987 Nazarali AJ, Baker GB, Coutts RT, Wong TF. N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain. Pharmaceutical Research. 4: 16-20. PMID 3508523 DOI: 10.1023/A:1016417624741  1
1987 Nazarali AJ, Baker GB, Coutts RT, Greenshaw AJ. Para-hydroxytranylcypromine: presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue. European Journal of Drug Metabolism and Pharmacokinetics. 12: 207-14. PMID 3436344 DOI: 10.1007/Bf03189899  1
1986 Vanderwolf CH, Baker GB. Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior. Brain Research. 374: 342-56. PMID 2941111 DOI: 10.1016/0006-8993(86)90428-2  1
1984 Vanderwolf CH, Gutman M, Baker GB. Hypothalamic self-stimulation: the role of dopamine and possible relations to neocortical slow wave activity. Behavioural Brain Research. 12: 9-19. PMID 6732919 DOI: 10.1016/0166-4328(84)90198-0  1
1984 Beck CH, Chow HL, Baker GB, Coutts RT. P-chloroamphetamine and a side-chain fluorinated analog: effects on brain amine levels and behavior. Pharmacology, Biochemistry, and Behavior. 20: 215-20. PMID 6718450 DOI: 10.1016/0091-3057(84)90245-4  1
1983 Mckim RH, Calverley DG, Dewhurst WG, Baker GB. Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine Progress in Neuropsychopharmacology and Biological Psychiatry. 7: 783-786. PMID 6141618 DOI: 10.1016/0278-5846(83)90066-0  1
1982 Baker GB, Martin IL, Coutts RT, Benderly A. Para-chlorophenylethylamine in brains of rats treated with a monoamine oxidase inhibitor and p-chlorophenylalanine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 6: 343-6. PMID 6219431 DOI: 10.1016/S0278-5846(82)80103-6  1
1981 Baker GB, Coutts RT, Martin IL. Analysis of amines in the central nervous system by gas chromatography with electron-capture detection. Progress in Neurobiology. 17: 1-24. PMID 6798635 DOI: 10.1016/0301-0082(81)90002-2  1
1981 Robertson HA, Baker GB, Coutts RT, Benderly A, Locock RA, Martin IL. Interactions of beta-carbolines with the benzodiazepine receptor: structure-activity relationships. European Journal of Pharmacology. 76: 281-4. PMID 6277646 DOI: 10.1016/0014-2999(81)90515-X  1
1980 Philips SR, Baker GB, McKim HR. Effects of tranylcypromine on the concentrations of some trace amines in the diencephalon and hippocampus of the rat Experientia. 36: 241-242. PMID 7371771 DOI: 10.1007/BF01953756  1
1980 Baker GB, Martin IL, Coutts RT, Benderly A. Determination of 5-hydroxytryptamine in rat brain regions by gas-liquid chromatography with electron-capture detection. Journal of Pharmacological Methods. 3: 173-9. PMID 6930528 DOI: 10.1016/0160-5402(80)90027-3  1
1978 Martin IL, Baker GB, Fleetwood-Walker SM. Modification of the radioenzymatic assay for the catecholamines. Biochemical Pharmacology. 27: 1519-20. PMID 697894 DOI: 10.1016/0006-2952(78)90478-1  1
1978 Martin IL, Baker GB, Mitchell PR. The effect of viloxazine hydrochloride on the transport of noradrenaline, dopamine, 5-hydroxytryptamine and gamma-amino-butyric acid in rat brain tissue. Neuropharmacology. 17: 421-3. PMID 673157 DOI: 10.1016/0028-3908(78)90018-7  1
1977 Martin IL, Baker GB. A gas-liquid chromatographic method for the estimation of 2-phenylethylamine in rat brain tissue. Biochemical Pharmacology. 26: 1513-6. PMID 901569 DOI: 10.1016/0006-2952(77)90424-5  1
1976 Martin IL, Baker GB. Procedural difficulties in the gas-liquid chromatographic assay of the arylalkylamines. Journal of Chromatography. 123: 45-50. PMID 950358 DOI: 10.1016/S0021-9673(00)81100-0  1
1975 Boulton AA, Baker GB. THE SUBCELLULAR DISTRIBUTION OF β‐PHENYLETHYLAMINE, p‐TYRAMINE AND TRYPTAMINE IN RAT BRAIN Journal of Neurochemistry. 25: 477-481. PMID 1151384 DOI: 10.1111/j.1471-4159.1975.tb04353.x  1
1974 Boulton AA, Baker GB. The subcellular distribution of some monoamines following their intraventricular injection into the rat Canadian Journal of Biochemistry. 52: 288-293. PMID 4598454 DOI: 10.1139/o74-045  1
Show low-probability matches.